NRx Pharmaceuticals, Inc.NRXPNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
72.45%
↑ 109% above average
Average (32q)
-823.89%
Historical baseline
Range
High:544.86%
Low:-11850.00%
Volatility
-1504.4%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 72.45% |
| Q2 2025 | -188.24% |
| Q1 2025 | 60.47% |
| Q4 2024 | -473.33% |
| Q3 2024 | 80.00% |
| Q2 2024 | -1.35% |
| Q1 2024 | -1334.11% |
| Q4 2023 | 93.03% |
| Q3 2023 | -516.67% |
| Q2 2023 | 36.84% |
| Q1 2023 | -120.67% |
| Q4 2022 | 38.50% |
| Q3 2022 | -110.84% |
| Q2 2022 | 63.11% |
| Q1 2022 | 70.00% |
| Q4 2021 | -57.89% |
| Q3 2021 | 99.38% |
| Q2 2021 | -8533.80% |
| Q1 2021 | 95.76% |
| Q4 2020 | -11850.00% |
| Q3 2020 | -4927.59% |
| Q2 2020 | 101.93% |
| Q1 2020 | 6.25% |
| Q4 2019 | -858.29% |
| Q3 2019 | -66.51% |
| Q2 2019 | -8.70% |
| Q1 2019 | 544.86% |
| Q4 2018 | 0.00% |
| Q3 2018 | 528.00% |
| Q2 2018 | -141.67% |
| Q1 2018 | 110.79% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |